Targeting Leukemia Initiating Cells by MUC1-C Subunit Inhibition

被引：3
|
作者：
Stroopinsky, Dina [1 ]
Rosenblatt, Jacalyn [1 ]
Mills, Heidi [1 ]
Nardella, Caterina [1 ]
Ito, Keisuke [1 ]
Yin, Li [2 ]
Rajabi, Hasan [2 ]
Vasir, Baldev [2 ]
Kufe, Turner [1 ]
Luptakova, Katarina [1 ]
Arnason, Jon E. [1 ]
Levine, James D. [1 ]
Joyce, Robin [1 ]
Tzachanis, Dimitrios [1 ]
Boussiotis, Vassiliki A. [1 ]
Galinsky, Ilene [2 ]
Stone, Richard M. [2 ]
Reiter, Yoram [3 ]
Pandolfi, Pier Paolo [1 ]
Kufe, Donald [2 ]
Avigan, David [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Technion Israel Inst Technol, Haifa, Israel
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.3583.3583
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3583
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Correction: Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein
    C. Jin
    H. Rajabi
    C. M. Rodrigo
    J. A. Porco
    D. Kufe
    Oncogene, 2021, 40 : 3347 - 3347
  • [32] MUC1-C oncoprotein suppresses reactive oxygen species-induced terminal differentiation of acute myelogenous leukemia cells
    Yin, Li
    Wu, Zekui
    Avigan, David
    Rosenblatt, Jacalyn
    Stone, Richard
    Kharbanda, Surender
    Kufe, Donald
    BLOOD, 2011, 117 (18) : 4863 - 4870
  • [33] Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer
    Hata, Tsuyoshi
    Rajabi, Hasan
    Yamamoto, Masaaki
    Jin, Caining
    Ahmad, Rehan
    Zhang, Yan
    Kui, Ling
    Li, Wei
    Yasumizu, Yota
    Hong, Deli
    Miyo, Masaaki
    Hiraki, Masayuki
    Maeda, Takahiro
    Suzuki, Yozo
    Takahashi, Hidekazu
    Samur, Mehmet
    Kufe, Donald
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (10) : 1744 - 1754
  • [34] Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
    Masayuki Hiraki
    Takahiro Maeda
    Neha Mehrotra
    Caining Jin
    Maroof Alam
    Audrey Bouillez
    Tsuyoshi Hata
    Ashujit Tagde
    Amy Keating
    Surender Kharbanda
    Harpal Singh
    Donald Kufe
    Signal Transduction and Targeted Therapy, 3
  • [35] Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
    Caroline Jochems
    Jo A. Tucker
    Matteo Vergati
    Benjamin Boyerinas
    James L. Gulley
    Jeffrey Schlom
    Kwong-Yok Tsang
    Cancer Immunology, Immunotherapy, 2014, 63 : 161 - 174
  • [36] MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia
    Tagde, Ashujit
    Rajabi, Hasan
    Stroopinsky, Dina
    Gali, Reddy
    Alam, Maroof
    Bouillez, Audrey
    Kharbanda, Surender
    Stone, Richard
    Avigan, David
    Kufe, Donald
    ONCOTARGET, 2016, 7 (26) : 38974 - 38987
  • [37] Intracellular Targeting of the Oncogenic MUC1-C Protein with a Novel GO-203 Nanoparticle Formulation
    Hasegawa, Masanori
    Sinha, Raj Kumar
    Kumar, Manoj
    Alam, Maroof
    Yin, Li
    Raina, Deepak
    Kharbanda, Akriti
    Panchamoorthy, Govind
    Gupta, Dikshi
    Singh, Harpal
    Kharbanda, Surender
    Kufe, Donald
    CLINICAL CANCER RESEARCH, 2015, 21 (10) : 2338 - 2347
  • [38] Targeting MUC1-C reverses the cisplatin resistance of esophageal squamous cell carcinoma in vitro and in vivo
    Zhao, Yong-Qiang
    Wu, Ting
    Wang, Li-Feng
    Yin, Bo
    Shi, Mo
    Jiang, Bin
    Gong-Sun, Xin
    Song, Xue-Min
    Liu, Xiang-Yan
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (02) : 645 - 655
  • [39] Understanding the Physical Principles that Mediate MUC1-C Homodimerization
    King, Jessica
    Schoepe, Isabella
    Iaccarino, Nicholas
    El Naccache, Darine
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 609A - 609A
  • [40] Correction: MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells
    Hasan Rajabi
    Tsuyoshi Hata
    Wei Li
    Mark D. Long
    Qiang Hu
    Song Liu
    Deepak Raina
    Ling Kui
    Yota Yasumizu
    Deli Hong
    Mehmet Samur
    Donald Kufe
    Oncogene, 2019, 38 : 7278 - 7278
12345